Vernakalant hydrochloride for the rapid conversion of atrial fibrillation after cardiac surgery: a randomized, double-blind, placebo-controlled trial.
about
The vernakalant story: how did it come to approval in Europe and what is the delay in the U.S.A?Vernakalant is superior to ibutilide for achieving sinus rhythm in patients with recent-onset atrial fibrillation: a randomized controlled trial at the emergency department.Suitability, efficacy, and safety of vernakalant for new onset atrial fibrillation in critically ill patients.A novel treatment strategy of new onset atrial fibrillation after cardiac surgery: an observational prospective study.Antiarrhythmic drugs for atrial fibrillation.Pharmacological management of atrial fibrillation: one, none, one hundred thousand.Advances in the Pharmacological Treatment of Atrial Fibrillation.Medication management of atrial fibrillation: emerging therapies for rhythm control and stroke prevention.Rate-dependent effects of vernakalant in the isolated non-remodeled canine left atria are primarily due to block of the sodium channel: comparison with ranolazine and dl-sotalolSafety and efficacy of vernakalant for the conversion of atrial fibrillation to sinus rhythm; a phase 3b randomized controlled trialCurrent issues in atrial fibrillation.Novel anti-arrhythmic medications in the treatment of atrial fibrillationAnti-Arrhythmic Agents in the Treatment of Atrial Fibrillation.Conversion of Recent-Onset Atrial Fibrillation: Which Drug is the Best?Management of atrial fibrillation in critically ill patients.Atrial fibrillation-the final frontier.Ultra-rapid delayed rectifier channels: molecular basis and therapeutic implications.The pharmaceutical pipeline for atrial fibrillation.Intravenous vernakalant: a review of its use in the management of recent-onset atrial fibrillation.Treating arrhythmias: an expert opinion.Spotlight on intravenous vernakalant in recent-onset atrial fibrillation.Minimizing cardiac risk in perioperative practice - interdisciplinary pharmacological approaches.Efficacy and safety of vernakalant in recent-onset atrial fibrillation after the European medicines agency approval: systematic review and meta-analysis.Recent clinical trials in atrial fibrillation in hypertensive patients.Safety and efficacy of pharmacological cardioversion of atrial fibrillation using intravenous vernakalant, a new antiarrhythmic drug with atrial selectivity.A new antiarrhythmic drug in the treatment of recent-onset atrial fibrillation: vernakalant.Clinical update on the management of atrial fibrillation.Safety and efficacy of vernakalant for acute cardioversion of atrial fibrillation: an update.Vernakalant hydrochloride to treat atrial fibrillation.Vernakalant for the conversion of atrial fibrillation: the new kid on the block?Postoperative atrial fibrillation in non-cardiac and cardiac surgery: an overview.Antiarrhythmic Drug Therapy for Rhythm Control in Atrial Fibrillation.The burden of proof: The current state of atrial fibrillation prevention and treatment trials.Efficacy and Safety of Vernakalant for Cardioversion of Recent-onset Atrial Fibrillation in the Asia-Pacific Region: A Phase 3 Randomized Controlled Trial.Advances in the Pharmacologic Management of Atrial Fibrillation.Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).Propafenone versus vernakalant for conversion of recent-onset atrial fibrillation.Population pharmacokinetics of vernakalant hydrochloride injection (RSD1235) in patients with atrial fibrillation or atrial flutter.[Atrial fibrillation in the ICU. Distinct entity--special treatment?].Body piercing and psychopathology: a review of the literature.
P2860
Q27022258-D707B35E-0884-462C-8591-8187C5D9D327Q33589789-33C8BBA5-B1CB-4621-B45F-796E32113C70Q33678288-2CCF3228-8414-48B8-9605-500F1E46E3DCQ33712294-4FB1E80F-255E-424F-B5D1-C9C79D791519Q33821199-D00418CE-960B-414E-92BB-3AEFE6325AEEQ33902193-0126093A-9C1F-49FE-A9F6-BBB5415988BFQ34383573-F6E26520-BC4F-4C56-B2E2-527760A735F7Q35209970-31805B87-E091-4318-99A6-72A37DE7D998Q35897567-76327650-14EF-42EE-B428-474ED076BEB6Q36032636-93119689-DB45-4E9C-A1DE-76024DBB8395Q36072140-0942880D-9AA3-4AE3-9F77-5FBEE64B2920Q36382379-45414350-515F-4BCB-A761-12A76ED8C908Q37495803-AC14B36A-E8C4-4214-BDD1-A4038E139B94Q37496339-8F495D02-5679-4C6A-896E-5144E2E244DEQ37556650-58614E4E-07AE-4E75-8C42-0ED85C87A8E9Q37799693-F0FE6ACD-ED94-4C79-B8D0-2E0E624A36F0Q37821136-F62AA61B-DFFE-4046-A425-FE80419281AFQ37821928-E7A4AF8D-920A-4D1D-92DE-53C8021EDC1BQ37833065-9243E2A3-A745-4414-B223-95C936405ADDQ37847185-D5254EB6-000A-422D-8384-D273935CDAF9Q37884567-13DBF63A-957E-4C29-8AF2-207C9C3CA899Q37892419-276A5A74-4789-4FCE-9E4F-AC566EB22332Q37968223-3C41FF0C-DD90-4160-AD9F-F449E0A2AB59Q38009238-DAB69BFA-F98B-47DA-883C-C7CCE4F23BA1Q38013221-61EC03A9-C48C-465C-A9FF-CE0249497851Q38080598-5A3639AC-5785-4284-BECC-ED2A4AE0338DQ38095871-612595D7-0000-4E75-A9B6-51B4D932A7AFQ38103541-13FD61C4-AB76-4FD8-BB27-B3A7AB7E1857Q38195102-C5374F01-3B49-49A3-BE63-E4511CBC92A3Q38205011-F393BF33-EA89-42CC-AFCA-1E05CAABB522Q38543307-618C7721-A464-4E9C-8342-A8C6DA6A30C8Q38853630-2B5E7FFC-8C21-43A5-96DC-029296861D60Q39119910-4037378D-B3AE-45BA-8743-EC6E3A99919EQ41974132-0F250551-4DBC-420D-9AE5-292B8AF4C844Q42777572-1D30F421-E358-4481-93F0-A6B47B9A20B8Q42923039-91E74414-0CEE-459B-8E75-65AD6899B23BQ44360762-36C54CE6-621F-4A6B-A917-57A4E95C53C0Q44963660-3FE5F7C2-9195-4CE1-94CF-DCCFECEB3A17Q45903533-FFE0221C-CE01-42DE-944F-D8F4DC834495Q45924284-3A93A4FE-9CDB-49B6-BB2C-FB6C53E9A4F5
P2860
Vernakalant hydrochloride for the rapid conversion of atrial fibrillation after cardiac surgery: a randomized, double-blind, placebo-controlled trial.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Vernakalant hydrochloride for ...... ind, placebo-controlled trial.
@en
type
label
Vernakalant hydrochloride for ...... ind, placebo-controlled trial.
@en
prefLabel
Vernakalant hydrochloride for ...... ind, placebo-controlled trial.
@en
P2093
P921
P1476
Vernakalant hydrochloride for ...... ind, placebo-controlled trial.
@en
P2093
Atrial Arrhythmia Conversion Trial Investigators
Craig M Pratt
Dorota Sobczyk
Jerzy Sadowski
L Brent Mitchell
Paul Dorian
Peter R Kowey
P304
P356
10.1161/CIRCEP.109.870204
P577
2009-12-01T00:00:00Z